Standard BioTools Inc.LABNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+24.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+24.3%/yr
vs +62.7%/yr prior
Acceleration
-38.4pp
Decelerating
Percentile
P97
Near historical high
vs 3Y Ago
1.9x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 52.40% |
| Q3 2025 | 8.68% |
| Q2 2025 | 22.06% |
| Q1 2025 | -0.47% |
| Q4 2024 | -3.46% |
| Q3 2024 | -4.81% |
| Q2 2024 | 49.72% |
| Q1 2024 | -181.41% |
| Q4 2023 | -1.01% |
| Q3 2023 | -21.34% |
| Q2 2023 | -5.16% |
| Q1 2023 | 21.40% |
| Q4 2022 | 27.27% |
| Q3 2022 | 24.73% |
| Q2 2022 | -40.21% |
| Q1 2022 | -144.28% |
| Q4 2021 | 42.59% |
| Q3 2021 | -13.57% |
| Q2 2021 | 10.62% |
| Q1 2021 | -14.29% |
| Q4 2020 | -209.37% |
| Q3 2020 | 60.19% |
| Q2 2020 | 8.14% |
| Q1 2020 | -62.75% |
| Q4 2019 | 33.55% |
| Q3 2019 | 5.60% |
| Q2 2019 | -3.03% |
| Q1 2019 | -27.77% |
| Q4 2018 | 4.39% |
| Q3 2018 | 9.05% |
| Q2 2018 | -1.20% |
| Q1 2018 | -44.64% |
| Q4 2017 | 44.02% |
| Q3 2017 | 5.37% |
| Q2 2017 | 5.98% |
| Q1 2017 | 0.91% |
| Q4 2016 | 4.25% |
| Q3 2016 | -1.88% |
| Q2 2016 | 3.85% |
| Q1 2016 | -37.81% |